Types Within the Biosensor for Diabetes segmentation, the types of biosensor are classified by transduction mechanism and reagent architecture, each influencing cost structure, performance envelope and market penetration. Enzymatic electrochemical sensors dominate the disposable strip market; they rely on glucose oxidase or glucose dehydrogenase to catalyze glucose oxidation, producing a current proportional to analyte concentration. Their manufacturing scalability yields low unit cost, supporting high volumes in SMBG applications. Non‑enzymatic electrochemical variants replace biocatalysts with metallic nanostructures (e.g., Pt, Au, Ni) that directly oxidize glucose, offering improved temperature stability and extended shelf life, yet they remain limited by selectivity challenges and higher material expense. Optical sensors, including fluorescence‑based and surface‑plasmon‑resonance platforms, provide label‑free detection and enable continuous monitoring without invasive insertion, positioning them for next‑generation CGM devices. Finally, hybrid electro‑optical systems combine amperometric readout with optical signal amplification to enhance sensitivity at low glucose concentrations, targeting neonatal intensive‑care and research settings. The relative contribution of each type to the overall market is governed by regulatory clearance pathways, reimbursement tiers and end‑user adoption curves, shaping the market taxonomy for diabetes biosensing.
